An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder

Olanzapine effectively treats schizophrenia and bipolar I disorder (BD-I); however, its use is limited by the risk of significant weight gain and metabolic effects. OLZ/SAM, a combination of olanzapine and samidorphan, was recently approved in the United States for the treatment of adults with schiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Citrome, Leslie, Graham, Christine, Simmons, Adam, Jiang, Ying, Todtenkopf, Mark S, Silverman, Bernard, DiPetrillo, Lauren, Cummings, Hannah, Sun, Lei, McDonnell, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437420/
https://www.ncbi.nlm.nih.gov/pubmed/34526769
http://dx.doi.org/10.2147/NDT.S313840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437420/
https://www.ncbi.nlm.nih.gov/pubmed/34526769
http://dx.doi.org/10.2147/NDT.S313840

Ejemplares similares